20 June 2013
Keywords: abraxis, appoints, merck, lax, van, der, ploeg
Article | 26 January 2009
The USA's Abraxis Bioscience has appointed Lex Van der Ploeg as senior vice president of integrative medicines and translational science. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 January 2009
19 January 2009
19 June 2013
© 2013 thepharmaletter.com